Forte Biosciences Inc

Stock Chart, Company Information, and Scan Results

$26.66(as of Apr 30, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Forte Biosciences Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$26.66

Ticker SymbolFBRX

ExchangeNasdaq

SectorHealthcare

IndustryBiotechnology

Employees19

CountyUSA

Market Cap$549.3M

EBIDTA-70.6M

10-Day Moving Average29.52

P/E Ratio-56.56

20-Day Moving Average29.72

Forward P/E Ratio0.00

50-Day Moving Average28.43

Earnings per Share-4.71

200-Day Moving Average20.58

Profit Margin-Infinity%

RSI43.83

Shares Outstanding19.6M

ATR2.67

52-Week High35.80

Volume148,954

52-Week Low6.13

Most Recent Support Level26.10

Book Value61.0M

Most Recent Resistance Level28.46

Upper Keltner35.74

P/S RatioInfinity

Lower Keltner23.70

Debt-to-Equity Ratio35.74

Next Earnings DateUnknown

Cash Surplus56.2M

Next Ex-Dividend DateUnknown

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Forte Biosciences Inc In Our Stock Scanner

As of Apr 30, 2026

example chart graphic

Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans

As of ---

example chart graphic

Scan Name: Cash SurplusScan Type: Stock Fundamentals

As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.